UNSPSC 51284008: Guamecycline

This classification denotes a tetracycline antibiotic with the molecular formula C29H38N8O8, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, 4NQR4R6G3S chemically known as n-((4-(amidinoamidino)-1-piperazinyl)methyl)-4-(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,6,10,12,12a-pentahydroxy-6-methyl-1,11-dioxo-2-naphthacenecarboxamide but generally known as guamecycline, which bears US NIH Compound Identifier 5464311.

UNSPSC 51284008 Guamecycline is a Commodity code that designates a specific antibiotic pharmaceutical product, but state and local procurement activity under this code shows no recent relevant solicitations. The two opportunities tagged to this code in recent months involve doxycycline and ciprofloxacin (neither guamecycline), and naloxone with drug deactivation systems — products unrelated to the code's nominal scope. State and local health departments and counties do procure antibiotics and emergency-response pharmaceuticals through piggyback contracts, cooperative purchasing vehicles, and competitive ITBs, but the available record does not show active demand specifically for guamecycline at this time.

Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC in August 2026 for doxycycline and ciprofloxacin under the MMCAP Infuse consortium, and Seminole County, Florida released an ITB in June 2026 for naloxone and drug deactivation systems with a July 2026 response deadline. These awards signal ongoing state and local procurement of pharmaceutical inventory through cooperative and competitive vehicles, but neither represents activity under the guamecycline code. If guamecycline procurement occurs at the state or local level, it does not appear in the recent solicitation record and warrants direct outreach to state health departments, county health systems, and emergency management agencies to assess actual demand.